Skip to main content
. Author manuscript; available in PMC: 2019 Jul 17.
Published in final edited form as: Vaccine. 2017 Apr 9;35(20):2668–2675. doi: 10.1016/j.vaccine.2017.03.082

Table 1.

Characteristics of influenza immunizations between July 1, 2007 and March 31, 2014 for children 2–18 years of age with a history of asthma prior to the immunization, Kaiser Permanente Northern California.

Characteristica Immunization Typec
All IIV LAIV
Number of unique children 154,994 143,013 35,624
Number of immunizations 387,633 330,807 56,826
Gender, n (%)
 Female 168,298 (43) 142,409 (43) 25,889 (46)
 Male 219,335 (57) 188,398 (57) 30,937 (54)
Age (years) at immunization, mean (median) 10.59 (10.77) 10.63 (10.87) 10.36 (10.28)
Age group (years), n (%)
 2 11,735 (3) 10,824 (3) 911 (2)
 3–4 38,119 (10) 33,046 (10) 5073 (9)
 5–7 71,212 (18) 59,201 (18) 12,011 (21)
 8–10 78,881 (20) 65,345 (20) 13,536 (24)
 11–14 110,105 (28) 94,061 (28) 16,044 (28)
 15+ 77,581 (20) 68,330 (21) 9251 (16)
Asthma type
 Current or recent, persistent 170,083 (44) 156,044 (47) 14,039 (25)
 Current or recent, not persistent 108,725 (28) 92,565 (28) 16,160 (28)
 Remote history of asthma only 108,825 (28) 82,198 (25) 26,627 (47)
Season of immunizationb
 2007 39,459 (10) 36,300 (11) 3159 (6)
 2008 43,668 (11) 36,218 (11) 7450 (13)
 2009 56,064 (14) 48,324 (15) 7740 (14)
 2010 52,976 (14) 44,648 (13) 8328 (15)
 2011 57,456 (15) 47,209 (14) 10,247 (18)
 2012 65,384 (17) 54,077 (16) 11,307 (20)
 2013 72,626 (19) 64,031 (19) 8595 (15)
a

For every characteristic, differences between IIV and LAIV children were significant at p ≥ 0.01.

b

“Season” is defined as running from July 1st of the year listed to June 30th of the following year.

c

IIV: inactivated influenza vaccine; LAIV: live attenuated influenza vaccine.